AstraZeneca to transfer global rights for Eklira and Duaklir to Covis Pharma
AstraZeneca said today (November 1) it will transfer global rights for respiratory medicines Eklira and Duaklir to Covis Pharma Group for about £198 million,...
Valneva’s Covid-19 vaccine will compete with AstraZeneca and J&J, says GlobalData
The newly launched Covid-19 vaccine by the French pharmaceutical company Valneva will compete with AstraZeneca and Johnson & Johnson (J&J) in the European market,...
New AstraZeneca, GSK lab to boost Covid-19 testing capacity
The UK will have a new coronavirus testing facility capable of carrying out 30,000 tests per day by early May, said the chief executive of pharma company AstraZeneca, helping...